Bcl-2 and Ki67 as specific prognostic markers in estrogen receptor positive breast cancers

被引：0
|
作者：
Jasar, D. [1 ]
Filipovski, V. [1 ]
Kubelka-Sabit, K. [1 ]
机构：
[1] Clin Hosp Acibadem Sistina, Dept Histopathol, Skopje, FY, Macedonia
来源：
VIRCHOWS ARCHIV | 2017年 / 471卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-017
引用
收藏
页码：S54 / S54
页数：1
相关论文
共 50 条
  • [31] Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers
    Yanai, Ayako
    Miyagawa, Yoshimasa
    Murase, Keiko
    Imamura, Michiko
    Yagi, Tomoko
    Ichii, Shigetoshi
    Takatsuka, Yuichi
    Ito, Takashi
    Hirota, Seiichi
    Sasa, Mitsunori
    Katagiri, Toyomasa
    Miyoshi, Yasuo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 467 - 472
  • [32] Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers
    Ayako Yanai
    Yoshimasa Miyagawa
    Keiko Murase
    Michiko Imamura
    Tomoko Yagi
    Shigetoshi Ichii
    Yuichi Takatsuka
    Takashi Ito
    Seiichi Hirota
    Mitsunori Sasa
    Toyomasa Katagiri
    Yasuo Miyoshi
    International Journal of Clinical Oncology, 2014, 19 : 467 - 472
  • [33] Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers
    Yagi, Tomoko
    Inoue, Natsuko
    Yanai, Ayako
    Murase, Keiko
    Imamura, Michiko
    Miyagawa, Yoshimasa
    Enomoto, Yukie
    Nishimukai, Arisa
    Takatsuka, Yuichi
    Hirota, Seiichi
    Akazawa, Kouhei
    Miyoshi, Yasuo
    BREAST CANCER, 2016, 23 (02) : 224 - 230
  • [34] Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers
    Tomoko Yagi
    Natsuko Inoue
    Ayako Yanai
    Keiko Murase
    Michiko Imamura
    Yoshimasa Miyagawa
    Yukie Enomoto
    Arisa Nishimukai
    Yuichi Takatsuka
    Seiichi Hirota
    Kouhei Akazawa
    Yasuo Miyoshi
    Breast Cancer, 2016, 23 : 224 - 230
  • [35] Ki-67 and Bcl-2 in colorectal polyps with breast cancer
    Gelincik, Ibrahim
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2011, 54 (02) : 307 - 311
  • [36] Expression of estrogen receptor, progesterone receptor, and ki67 in normal breast tissue and subsequent risk of breast cancer
    Oh, Hannah
    Eliassen, A. Heather
    Wang, Molin
    Smith-Warner, Stephanie A.
    Beck, Andrew H.
    Schnitt, Stuart J.
    Collins, Laura C.
    Connolly, James L.
    Montaser-Kouhsari, Laleh
    Tamimi, Rulla M.
    CANCER RESEARCH, 2015, 75
  • [37] P53, Bcl-2 and Ki67 immunoexpression in follicular solid ameloblastomas
    Florescu, Alma
    Simionescu, Cristiana
    Ciurea, Raluca
    Pitru, Allma
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2012, 53 (01): : 105 - 109
  • [38] Is Ki67 Effective as a Prognostic Marker in Node-Positive Breast Cancer Patients?
    Benli, Sami
    Aksoy, Suleyman Ozkan
    Sevinc, Ali Ibrahim
    Durak, Merih Guray
    Baysan, Caner
    INDIAN JOURNAL OF SURGERY, 2022, 84 (SUPPL 3) : 689 - 696
  • [39] Is Ki67 Effective as a Prognostic Marker in Node-Positive Breast Cancer Patients?
    Sami Benli
    Süleyman Özkan Aksoy
    Ali İbrahim Sevinç
    Merih Güray Durak
    Caner Baysan
    Indian Journal of Surgery, 2022, 84 : 689 - 696
  • [40] Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer
    Zilenaite-Petrulaitiene, Dovile
    Rasmusson, Allan
    Besusparis, Justinas
    Valkiuniene, Ruta Barbora
    Augulis, Renaldas
    Laurinaviciene, Aida
    Plancoulaine, Benoit
    Petkevicius, Linas
    Laurinavicius, Arvydas
    VIRCHOWS ARCHIV, 2025, 486 (02) : 287 - 298
12345